\nMASS VACCINATION WITH
\nPFIZER\u2019S RNA COVID-19 VACCINE<\/strong><\/h2>\n
By Bill Sardi<\/p>\n
News headlines claim 95% effectiveness
\nfor Pfizer RNA COVID-19 vaccine.
\nIn hard numbers, there is only a marginal (less than 1%) statistical advantage to vaccination
\ncompared to an inactive placebo vaccine.
\nThis deception will lead to
\nmassive overvaccination of the U.S. population.\u00a0 <\/strong><\/h3>\nKnowledge of Health, Dec. 9, 2020 – Analysis of data released by the FDA reveals mandated vaccination of the entire U.S. population with PFIZER\u2019S COVID-19 RNA vaccine would prevent less than 1% of COVID-19 cases.<\/p>\n
On December 10, 2020, the Food & Drug Administration, acting as a front-man for Pfizer drug company, released a seemingly positive report on the safety and effectiveness of a 2-dose RNA COVID-19 vaccine, claiming 95% effectiveness.<\/p>\n
The design for this ongoing vaccine study is intended to determine how well an RNA-altering COVID-19 vaccine reduces incidence of COVID-19 infection as determined by a PCR (polymerase chain reaction) nasal swab test and by symptomology over a short-term (sometime 7 days after the 2nd<\/sup> inoculation).\u00a0 The PFIZER Report is available for viewing and analysis<\/a>.<\/p>\nThe 2-inoculation regimen is used to reduce dose-related side effects.<\/p>\n
Both vaccinated and placebo groups experienced less than 1-percent infection rates in hard numbers, but on a relative basis vaccinated subjects experienced 95% less risk for infection.<\/p>\n
The chance of benefiting from vaccination is less than 1-percent because very few are infected in the first place.\u00a0 This scheme hides the fact massive overvaccination needs to occur to produce a health benefit for very few.<\/p>\n
Over all there were 9 cases of COVID-19 among 19,965 vaccinated subjects vs. 169 among 20,172 subjects in the placebo group. (9 divided by 169 = .05 or ~95% relative reduction in new cases of COVID-19). This is how investigators came up with the quoted 95% effectiveness for this vaccine.<\/p>\n
It should not be misconstrued that 95% effectiveness means 95 out of 100 benefited from vaccination by reduction of risk for infection.<\/p>\n
Over 38,000 subjects had to be inoculated to determine the number of lab-tested cases of COVID-19 were reduced from 169 to 9; (9 in 19,965 vaccinated subjects = 0.00045% or 4.5 cases in 10,000); compared to 162 COVID-19 infections among 20,172 that received an inactive placebo (0.00803% or 8 cases in 1000).\u00a0\u00a0<\/strong><\/p>\n![\"\"](\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2020\/12\/0-2.png\")
<\/p>\n
Extrapolated to entire US population (325,000,000)<\/strong><\/p>\nIf the data gleaned from the FDA\/PFIZER vaccine report were applied and the entire U.S. population was vaccinated, the above chart reveals the number of infected cases would dramatically drop to 146,250 compared to 2,609,750 cases if an inactive placebo were administered, but 325,000,000 Americans would have to be inoculated to achieve these numbers, with no assurance immunity would last, with no assurance deaths would decline, and with uncertainty whether side effects will exceed benefits.<\/p>\n
The RNA vaccine activated dormant viruses that resulted in cases of temporary facial nerve paralysis (Bell\u2019s palsy).<\/p>\n
A number of vaccines that have undergone more rigorous study than the current COVID-19 vaccines now being licensed have been recalled due to severe side effects<\/a>, some years after gaining licensure.<\/p>\nThe data reveals 99% of the U.S. population would not benefit from RNA-vaccination against COVID-19.\u00a0 There is the possibility the number of side effects will exceed the number of infections prevented.<\/p>\n
Public health authorities report 15.5 million accumulated cases of COVID-19 whereas the extrapolation presented here shows only 2,609,750 cases of COVID-19 infection with an inactive placebo vaccine.\u00a0 For explanation, the 15.5 is an accumulated number of cases while the 2,609,750 cases is tabulated at one point in time.<\/p>\n
Guesstimated deaths<\/strong><\/p>\n286,000 COVID-19-related deaths have been reported since January of 2020, or 53 cases for every death.\u00a0 (15.5 million cases divided by 286,000 deaths = 54)<\/p>\n
According to the Centers for Disease Control, only 6% of the reported 286,000 deaths are solely attributed to COVID-19<\/a> with the rest attributed to advanced age and co-existent weakened immune systems and co-morbid conditions such as diabetes and heart disease.<\/p>\nTherefore, the corrected number of deaths attributed solely to COVID-19 is 6% of 286,000 = 17,160 COVID-only deaths, which is a ratio of ~885 cases for every death without an effective vaccine.\u00a0 (17,160 COVID-19-only related deaths in a population of 325 million would be a 0.000053% death rate or 5.3 in 100,000).<\/p>\n
That would mean the number of subjects needed to treat (NNT) to prevent 1 death would be 885.\u00a0 That is the reason why COVID-19 death numbers need to be skewed higher in order to justify vaccination.\u00a0 Hence, older people who have comorbidities + a positive PCR COVID-19 test are considered to have died of COVID-19, not with COVID-19.<\/p>\n
Mandatory vaccination with Pfizer\u2019s yet unproven RNA vaccine would need to raise the number of cases required to produce 1 death (now 1 in 885), thus reducing risk, which would be a very challenging task.<\/p>\n
In the PFIZER vaccine study, there were 2 deaths in the RNA-vaccine group and 4 in the placebo group.\u00a0 Those deaths were not attributed to vaccination.\u00a0 Regardless of the numbers, there is no data to show \u00a0Pfizer\u2019s COVID-19 RNA vaccine reduces the COVID-19 death rate whatsoever. \u00a0Only a long-term study would reveal any survival benefit for vaccination.\u00a0 They study was not designed to determine death rate.<\/p>\n
When only 286,000 subjects (w\/comorbidities) die in a population of 325 million, that equals 8.8 deaths in 10,000 or 0.00088%.\u00a0 When only 17,160 die with COVID-19 (w\/o comorbidities), that is 5.3 deaths per 100,000 or 0.000053%.\u00a0 Either way, whichever mortality numbers are used, a lot of people have to be vaccinated to save 1 life.<\/p>\n
Any analyst would conclude, from these numbers, this is not a pandemic.\u00a0 Only a flawed PCR test and re-categorization of deaths produces the above mortality numbers.\u00a0 Even then, the chance of dying of or with COVID-19 is remote and contrived.<\/p>\n
The 2-inoculation regimen is used to reduce dose-related side effects.<\/p>\n
Both vaccinated and placebo groups experienced less than 1-percent infection rates in hard numbers, but on a relative basis vaccinated subjects experienced 95% less risk for infection.<\/p>\n
The chance of benefiting from vaccination is less than 1-percent because very few are infected in the first place.\u00a0 This scheme hides the fact massive overvaccination needs to occur to produce a health benefit for very few.<\/p>\n
Over all there were 9 cases of COVID-19 among 19,965 vaccinated subjects vs. 169 among 20,172 subjects in the placebo group. (9 divided by 169 = .05 or ~95% relative reduction in new cases of COVID-19). This is how investigators came up with the quoted 95% effectiveness for this vaccine.<\/p>\n
It should not be misconstrued that 95% effectiveness means 95 out of 100 benefited from vaccination by reduction of risk for infection.<\/p>\n
Over 38,000 subjects had to be inoculated to determine the number of lab-tested cases of COVID-19 were reduced from 169 to 9; (9 in 19,965 vaccinated subjects = 0.00045% or 4.5 cases in 10,000); compared to 162 COVID-19 infections among 20,172 that received an inactive placebo (0.00803% or 8 cases in 1000).\u00a0\u00a0<\/strong><\/p>\n Extrapolated to entire US population (325,000,000)<\/strong><\/p>\n If the data gleaned from the FDA\/PFIZER vaccine report were applied and the entire U.S. population was vaccinated, the above chart reveals the number of infected cases would dramatically drop to 146,250 compared to 2,609,750 cases if an inactive placebo were administered, but 325,000,000 Americans would have to be inoculated to achieve these numbers, with no assurance immunity would last, with no assurance deaths would decline, and with uncertainty whether side effects will exceed benefits.<\/p>\n The RNA vaccine activated dormant viruses that resulted in cases of temporary facial nerve paralysis (Bell\u2019s palsy).<\/p>\n A number of vaccines that have undergone more rigorous study than the current COVID-19 vaccines now being licensed have been recalled due to severe side effects<\/a>, some years after gaining licensure.<\/p>\n The data reveals 99% of the U.S. population would not benefit from RNA-vaccination against COVID-19.\u00a0 There is the possibility the number of side effects will exceed the number of infections prevented.<\/p>\n Public health authorities report 15.5 million accumulated cases of COVID-19 whereas the extrapolation presented here shows only 2,609,750 cases of COVID-19 infection with an inactive placebo vaccine.\u00a0 For explanation, the 15.5 is an accumulated number of cases while the 2,609,750 cases is tabulated at one point in time.<\/p>\n Guesstimated deaths<\/strong><\/p>\n 286,000 COVID-19-related deaths have been reported since January of 2020, or 53 cases for every death.\u00a0 (15.5 million cases divided by 286,000 deaths = 54)<\/p>\n According to the Centers for Disease Control, only 6% of the reported 286,000 deaths are solely attributed to COVID-19<\/a> with the rest attributed to advanced age and co-existent weakened immune systems and co-morbid conditions such as diabetes and heart disease.<\/p>\n Therefore, the corrected number of deaths attributed solely to COVID-19 is 6% of 286,000 = 17,160 COVID-only deaths, which is a ratio of ~885 cases for every death without an effective vaccine.\u00a0 (17,160 COVID-19-only related deaths in a population of 325 million would be a 0.000053% death rate or 5.3 in 100,000).<\/p>\n That would mean the number of subjects needed to treat (NNT) to prevent 1 death would be 885.\u00a0 That is the reason why COVID-19 death numbers need to be skewed higher in order to justify vaccination.\u00a0 Hence, older people who have comorbidities + a positive PCR COVID-19 test are considered to have died of COVID-19, not with COVID-19.<\/p>\n Mandatory vaccination with Pfizer\u2019s yet unproven RNA vaccine would need to raise the number of cases required to produce 1 death (now 1 in 885), thus reducing risk, which would be a very challenging task.<\/p>\n In the PFIZER vaccine study, there were 2 deaths in the RNA-vaccine group and 4 in the placebo group.\u00a0 Those deaths were not attributed to vaccination.\u00a0 Regardless of the numbers, there is no data to show \u00a0Pfizer\u2019s COVID-19 RNA vaccine reduces the COVID-19 death rate whatsoever. \u00a0Only a long-term study would reveal any survival benefit for vaccination.\u00a0 They study was not designed to determine death rate.<\/p>\n When only 286,000 subjects (w\/comorbidities) die in a population of 325 million, that equals 8.8 deaths in 10,000 or 0.00088%.\u00a0 When only 17,160 die with COVID-19 (w\/o comorbidities), that is 5.3 deaths per 100,000 or 0.000053%.\u00a0 Either way, whichever mortality numbers are used, a lot of people have to be vaccinated to save 1 life.<\/p>\n Any analyst would conclude, from these numbers, this is not a pandemic.\u00a0 Only a flawed PCR test and re-categorization of deaths produces the above mortality numbers.\u00a0 Even then, the chance of dying of or with COVID-19 is remote and contrived.<\/p>\n<\/p>\n
![\"\"](\"http:\/\/stateofthenation.co\/wp-content\/uploads\/2020\/12\/0-5-1.png\")
<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-41636","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/41636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41636"}],"version-history":[{"count":0,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=\/wp\/v2\/posts\/41636\/revisions"}],"wp:attachment":[{"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41636"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/stateofthenation.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}